Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

IRTC iRhythm Technologies Inc

Price (delayed)

$141

Market cap

$4.5B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.14

Enterprise value

$4.85B

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based ...

Highlights
The EPS has increased by 26% YoY and by 13% from the previous quarter
The company's gross profit rose by 25% YoY and by 5% QoQ
The quick ratio has contracted by 20% YoY and by 2.7% from the previous quarter
IRTC's equity is down by 4.7% since the previous quarter and by 4% year-on-year

Key stats

What are the main financial stats of IRTC
Market
Shares outstanding
31.93M
Market cap
$4.5B
Enterprise value
$4.85B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
51.1
Price to sales (P/S)
7.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.85
Earnings
Revenue
$618.59M
Gross profit
$429.23M
Operating income
-$109.92M
Net income
-$98.32M
EBIT
-$83.89M
EBITDA
-$57.89M
Free cash flow
$13.94M
Per share
EPS
-$3.14
EPS diluted
-$3.14
Free cash flow per share
$0.44
Book value per share
$2.76
Revenue per share
$19.58
TBVPS
$29.29
Balance sheet
Total assets
$926.1M
Total liabilities
$839.43M
Debt
$735.5M
Equity
$86.67M
Working capital
$524.67M
Liquidity
Debt to equity
8.49
Current ratio
5.71
Quick ratio
5.47
Net debt/EBITDA
-6.08
Margins
EBITDA margin
-9.4%
Gross margin
69.4%
Net margin
-15.9%
Operating margin
-17.8%
Efficiency
Return on assets
-10.7%
Return on equity
-112.8%
Return on invested capital
-7.8%
Return on capital employed
-10.3%
Return on sales
-13.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IRTC stock price

How has the iRhythm Technologies stock price performed over time
Intraday
-0.03%
1 week
2.4%
1 month
41.07%
1 year
42.86%
YTD
56.37%
QTD
34.7%

Financial performance

How have iRhythm Technologies's revenue and profit performed over time
Revenue
$618.59M
Gross profit
$429.23M
Operating income
-$109.92M
Net income
-$98.32M
Gross margin
69.4%
Net margin
-15.9%
The net margin is up by 37% YoY and by 17% from the previous quarter
IRTC's operating margin is up by 26% YoY and by 9% from the previous quarter
The company's gross profit rose by 25% YoY and by 5% QoQ
The company's net income rose by 24% YoY and by 13% QoQ

Price vs fundamentals

How does IRTC's price correlate with its fundamentals

Growth

What is iRhythm Technologies's growth rate over time

Valuation

What is iRhythm Technologies stock price valuation
P/E
N/A
P/B
51.1
P/S
7.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.85
The EPS has increased by 26% YoY and by 13% from the previous quarter
IRTC's P/B is 157% above its 5-year quarterly average of 19.9 and 51% above its last 4 quarters average of 33.8
IRTC's equity is down by 4.7% since the previous quarter and by 4% year-on-year
The P/S is 41% above the last 4 quarters average of 5.1 but 27% below the 5-year quarterly average of 9.9
The revenue has grown by 21% YoY and by 4.5% from the previous quarter

Efficiency

How efficient is iRhythm Technologies business performance
IRTC's return on invested capital has surged by 64% year-on-year and by 18% since the previous quarter
iRhythm Technologies's ROE has plunged by 61% YoY but it has increased by 12% from the previous quarter
The ROA has soared by 54% YoY and by 13% from the previous quarter
The ROS has increased by 44% YoY and by 20% from the previous quarter

Dividends

What is IRTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRTC.

Financial health

How did iRhythm Technologies financials performed over time
IRTC's total assets is 10% greater than its total liabilities
The current ratio has declined by 20% year-on-year
The quick ratio has contracted by 20% YoY and by 2.7% from the previous quarter
The debt to equity has grown by 4.7% from the previous quarter and by 4% YoY
IRTC's equity is down by 4.7% since the previous quarter and by 4% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.